The total return over the past 12 months is +12.15% vs. +16.94% for the S&P 500. So far it's up +49.89% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +12.15% | +4.31% | +0.35% | +24.23% | +1.03% | +6.46% |
| Total Return CAGR | +12.15% | +4.31% | +0.35% | +24.23% | +1.03% | +6.46% |
| Revenue CAGR | +12.93% | +22.56% | +40.06% | +39.40% | +31.09% | +36.93% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +56.12% | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Sanara MedTech Inc. (SMTI)
| Year | Start price | End price | SMTI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $23.35 | $35.00 | +49.89% | +14.51% | +35.38% |
| 2025 | $33.20 | $23.35 | (29.67%) | +17.72% | (47.39%) |
| 2024 | $41.10 | $33.20 | (19.22%) | +24.89% | (44.11%) |
| 2023 | $45.50 | $41.10 | (9.67%) | +26.19% | (35.86%) |
| 2022 | $29.55 | $45.50 | +53.98% | (18.17%) | +72.15% |
| 2021 | $49.90 | $29.55 | (40.78%) | +28.74% | (69.52%) |
| 2020 | $16.10 | $49.90 | +209.94% | +18.37% | +191.57% |
| 2019 | $3.00 | $16.10 | +436.67% | +31.22% | +405.45% |
| 2018 | $6.00 | $3.00 | (50.00%) | (4.56%) | (45.44%) |
| 2017 | $4.00 | $6.00 | +50.00% | +21.70% | +28.30% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
